5246.0: Wednesday, November 15, 2000: 4:30 PM-6:00 PM | ||||
| ||||
See individual abstracts for presenting author's disclosure statement. | ||||
Learning Objectives: Refer to the individual abstracts for learning objectives | ||||
Ethical concerns when conducting research in refugees and survivors of torture Alejandro Moreno, MD, Michael A. Grodin, MD | ||||
Balancing individual rights and societal interests: Tuberculosis prevention policies for active substance users Chau Trinh, MS, David C. Perlman, MD, Ronald Bayer, PhD, Mary E. Northridge, PhD, Nadim Salomon, MD, Don C. Des Jarlais, PhD | ||||
Preventing medical errors: The moral imperative to "do no harm" Gopal Sankaran, MD, DrPH | ||||
Defining "serious" genetic disorders: results of a professional survey Dorothy C. Wertz, PhD, Bartha Maria Knoppers, JD, Ruth Chadwick, PhD | ||||
Ethical analysis of recruitment strategies in research on sexual behavior and illicit drug use Lewis H. Margolis, MD, MPH | ||||
Determining the Role of Genetic Testing in Managed Health Care Evelyn Tate, Howard Chang, Jared Goldberg, Sam Alcaine, Bill Davis, Mark Kimball, Kerry Kimes, Russell Logan, Tom Yee | ||||
Ethical dilemmas in research with adolescents: When can they consent? Kathleen L. Whitten, MA | ||||
Finnish physicians' interest in genetic screening K. Elina Hemminki, Prof, Hanna Toiviainen, MSc | ||||
Gene therapy's promise and tragedy: Reforming consent and oversight Rosemary B. Quigley, AB | ||||
Written informed consent forms: information or information overload? Louise-Anne McNutt, PhD, Bonnie E Carlson, PhD, Jerou S Kotval, PhD | ||||
Sponsor: | Forum on Bioethics |